SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Rho JM, Storey TW. Molecular ontogeny of major neurotransmitter receptors in the mammalian central nervous system: adrenergic, dopamine, serotonin, acetylcholine, and glycine receptors. J Child Neurol 2001;16: 27180.
  • 2
    Simeone TA, Donevan SD, Rho JM. Molecular biology and ontogeny of GABAA and GABAB receptors in the mammalian central nervous system. J Child Neurol 2003;18: 3948.
  • 3
    Simeone TA, Sanchez RM, Rho JM. Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system. J Child Neurol 2004;19: 34360.
  • 4
    Blume WT. Pathogenesis of Lennox-Gastaut syndrome: considerations and hypotheses. Epileptic Disord 2001;3: 18396.
  • 5
    Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990;61: 9317.
  • 6
    Vesa J, Hellsten E, Verkruyse LA, et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995;376: 5847.
  • 7
    Pennacchio LA, Lehesjoki AE, Stone NE, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271: 17314.
  • 8
    Minassian BA, Lee JR, Herbrick JA, et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 1998;20: 1714.
  • 9
    Noebels JL. The biology of epilepsy genes. Annu Rev Neurosci 2003;26: 599625.
  • 10
    DulacO, ChuganiH, Dalla BernadinaB, eds. Infantile spasms and West syndrome. London : WB Saunders, 1994.
  • 11
    Delgado-EscuetaAV, WilsonWA, OlsenRW, PorterRJ, eds. Jasper's basic mechanisms of the epilepsies. Philadelphia , PA : Lippincott Williams & Wilkins, 1999. Advances in Neurology; Vol. 39. 3rd ed.
  • 12
    SchwartzkroinPA, RhoJM, eds. Epilepsy, infantile spasms, and developmental encephalopathy. New York , NY : Academic Press, 2002. International Review of Neurobiology, Volume 49.
  • 13
    SutulaT, PitkänenA, eds. Do seizures damage the brain. Progress in Brain Research, Vol. 135, Amsterdam : Elsevier, 2002.
  • 14
    Pranzatelli MR. On the molecular mechanism of adrenocorticotrophic hormone in the CNS: neurotransmitters and receptors. Exp Neurol 1994;125: 14261.
  • 15
    Hol EM, Gispen WH, Bar PR. ACTH-related peptides: receptors and signal transduction systems involved in their neurotrophic and neuroprotective actions. Peptides 1995;16: 97993.
  • 16
    Gallo-Payet N, Payet MD. Mechanism of action of ACTH: beyond cAMP. Microsc Res Tech 2003;61: 27587.
  • 17
    Jung MJ, Lippert B, Metcalf BW, Bohlen P, Schechter PJ. gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 1977;29: 797802.
  • 18
    Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996;47: 156771.
  • 19
    Errante LD, Williamson A, Spencer DD, Petroff OA. Gabapentin and vigabatrin increase GABA in the human neocortical slice. Epilepsy Res 2002;49: 20310.
  • 20
    Baram TZ. Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis. Ann Neurol 1993;33: 2316.
  • 21
    Brunson KL, Eghbal-Ahmadi M, Bender R, Chen Y, Baram TZ. Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci ( USA ) 2001a;98: 885661.
  • 22
    Brunson KL, Khan N, Eghbal-Ahmadi M, Baram TZ. Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann Neurol 2001b;49: 30412.
  • 23
    Brunson KL, Avishai-Eliner S, Baram TZ. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 2002;49: 18597.
  • 24
    Avishai-Eliner S, Brunson KL, Sandman CA, Baram TZ. Stressed-out, or in (utero)?Trends Neurosci 2002;25: 51824.
  • 25
    Chiron C, Dulac O, Beaumont D, Palacios L, Pajot N, Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991;(suppl 2):S529.
  • 26
    Elterman RD, Shields WD, Mansfield KA, Nakagawa J, and the US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001;57: 141621.
  • 27
    Lux AL, Edwards SW, Osborne JP, et al. Randomized trial of vigabatrin in patients with infantile spasms. [Letter]Neurology 2002;59: 648.
  • 28
    Baram TZ, Mitchell WG, Tournay A, Snead III OC, Hanson RA, Horton EG. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97: 3759.
  • 29
    Baram TZ, Hirsch E, Snead III OC, Schultz L. Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol 1992a;31: 48894.
  • 30
    Baram TZ, Hatalski CB. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998;21: 4716.
  • 31
    Nalin A, Facchinetti F, Galli V, Petraglia F, Storchi R, Genazzani AR. Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. Epilepsia 1985;26: 4469.
  • 32
    Baram TZ, Mitchell WG, Snead III OC, Horton EJ, Saito M. Brain adrenal axis hormones are altered in the CSF of infants with massive infantile spasms. Neurology 1992b;42: 11715.
  • 33
    Avishai-Eliner S, Yi SJ, Baram TZ. Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res 1996;91: 15963.
  • 34
    Pentella K, Bachman DS, Sandman CA. Trial of an ACTH 4-9 analogue in chlidren with intractable seizures. Neuropediatrics 1982;13: 5962.
  • 35
    Willig RP, Lagenstein I. Use of ACTH fragments in children with infantile spasms. Neuropediatrics 1982;13: 558.
  • 36
    Tran V, Hatalski CG, Yan XX, Baram TZ. Effects of blocking GABA degradation on corticotropin-releasing hormone gene expression in selected brain regions. Epilepsia 1999;40: 11907.
  • 37
    McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990;15: 4170.
  • 38
    Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 1999;51: 761.
  • 39
    Tremblay E, Roisin MP, Represa A, Charriaut-Marlangue C, Ben-Ari Y. Transient increased density of NMDA binding sites in the developing rat hippocampus. Brain Res 1988;461: 3936.
  • 40
    Represa A, Tremblay E, Ben-Ari Y. Transient increase of NMDA-binding sites in human hippocampus during development. Neurosci Lett 1989;99: 616.
  • 41
    Hardingham GE, Bading H. The yin and yang of NMDA receptor signaling. Trends Neurosci 2003;26: 819.
  • 42
    Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL. GABAA, NMDA and AMPA receptors: a developmentally regulated ‘menage à trois’. Trends Neurosci 1997;20: 5239.
  • 43
    Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 1997;20: 46470.
  • 44
    Mares P, Velisek L. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Brain Res Dev Brain Res 1992;65: 1859.
  • 45
    Kabova R, Liptakova S, Slamberova R, Pometlova M, Velisek L. Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 1999;40: 135769.
  • 46
    Kohl BK, Dannhardt G. The NMDA receptor complex: a promising target for novel antiepileptic strategies. Curr Med Chem 2001;8: 127589.
  • 47
    Ritter FJ, Leppik IE, Dreifuss FE, and the Felbamate Study Group. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). The felbamate study group in Lennox-Gastaut syndrome. N Engl J Med 1993;328: 2933.
  • 48
    Rho JM, Donevan SD, Rogawski MA. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and γ-aminobutyric acidA receptors. Ann Neurol 1994;35: 22934.
  • 49
    Harty TP, Rogawski MA. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit. Epilepsy Res 2000;39: 4755.
  • 50
    Pranzatelli MR. Infantile spasms versus myoclonus: is there a connection Int Rev Neurobiol 2002;49: 285314.
  • 51
    Pranzatelli MR. Antimyoclonic effect of MK-801: a possible role for NMDA receptors in developmental myoclonus of the neonatal rat. Clin Neuropharmacol 1990;13: 32938.
  • 52
    Silverstein F, Johnston MV. Cerebrospinal fluid monoamine metabolites in patients with infantile spasms. Neurology 1984;34: 1025.
  • 53
    Langlais PJ, Wardlow ML, Yamamoto H. Changes in CSF neurotransmitters in infantile spasms. Pediatr Neurol 1991;7: 4405.
  • 54
    Yamamoto H. Studies on CSF tryptophan metabolism in infantile spasms. Pediatr Neurol 1991;17: 4114.
  • 55
    Azmitia EC, Gannon PJ, Kheck NM, Whitaker-Azmitia PM. Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacol 1996;14: 3546.
  • 56
    Riad M, Emerit MB, Hamon M. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture. Brain Res Dev Brain Res 1994;82: 24558.
  • 57
    Chugani HT, Shewmon DA, Sankar R, Chen BC, Phelps ME. Infantile spasms: II. lenticular nuclei and brainstem activation on positron emission tomography. Ann Neurol 1992;31: 2129.
  • 58
    Chugani HT, Shields WD, Shewmon DA, Olson DM, Phelps ME, Peacock WJ. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990;27: 40613.
  • 59
    Chugani HT, Rintahaka PJ, Shewmon DA. Ictal patterns of cerebral glucose utilization in children with epilepsy. Epilepsia 1994;35: 81322.
  • 60
    Juhász C, Chugani HT, Muzik O, Chugani DC. Hypotheses from functional neuroimaging studies. Int Rev Neurobiol 2002;49: 3755.
  • 61
    Chugani DC, Chugani HT, Muzik O, et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 1998;44: 85866.
  • 62
    Yamamoto H, Shindo I, Egawa B, Horiguchi K. Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms. Pediatr Neurol 1994;10: 912.
  • 63
    Stafstrom CE, Holmes GL. Infantile spasms: criteria for an animal model. Int Rev Neurobiol 2002;49: 391411.
  • 64
    Kanehisa M. A database for post-genome analysis. Trends Genet 1997;13: 3756.
  • 65
    Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28: 2730.